ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-10.21	-18.52	18.78	-47.9	-42.6	-22.55
Depreciation & Amortization	84.52	67.73	59.79	59.65	47.25	44.64
Loss (Gain) From Sale of Assets	-	-5.35	-	-0.75	-1.82	-
Asset Writedown & Restructuring Costs	7.6	7.6	-	1.73	2.37	4.2
Loss (Gain) From Sale of Investments	1.23	-6.31	-	-	-	-
Stock-Based Compensation	33.02	29.34	20.65	14.6	10.49	12.94
Other Operating Activities	-18.12	0.7	-5.12	-7.23	-12.28	-11.33
Change in Accounts Receivable	-20.78	-21.09	3.36	-36.91	-5.55	-23.66
Change in Inventory	-8.57	-21.29	-5.84	-23.63	3.22	-2.76
Change in Accounts Payable	-1.28	0.48	7.55	5.04	10.17	-2.29
Change in Income Taxes	6.16	-1.42	11.99	-0.16	-7.57	4.98
Change in Other Net Operating Assets	65.58	32.13	7.8	4.36	-0.35	11.11
Operating Cash Flow	139.14	64.02	118.96	-31.2	3.32	15.27
Operating Cash Flow Growth	23.58%	-46.19%	-	-	-78.24%	-66.54%
Capital Expenditures	-13.69	-16.24	-8.87	-8.88	-2.56	-6.14
Sale of Property, Plant & Equipment	-	13.51	-	0.75	2.65	-
Cash Acquisitions	-401.28	-401.28	-	-0.03	-84.49	-
Sale (Purchase) of Intangibles	-20.98	-0.72	-9.64	-7.58	-21.08	-62.19
Investing Cash Flow	-435.96	-404.72	-18.51	-15.74	-105.48	-68.32
Long-Term Debt Issued	-	641.25	-	-	310.03	15
Long-Term Debt Repaid	-	-296.03	-3	-3	-211.01	-15.53
Total Debt Repaid	-298.59	-296.03	-3	-3	-211.01	-15.53
Net Debt Issued (Repaid)	342.66	345.22	-3	-3	99.02	-0.53
Issuance of Common Stock	6.67	6.49	89.55	1.46	71.65	0.62
Repurchase of Common Stock	-11.55	-10.96	-4.99	-1.96	-0.89	-1.52
Preferred Dividends Paid	-1.63	-1.63	-1.63	-1.63	-0.19	-
Dividends Paid	-1.63	-1.63	-1.63	-1.63	-0.19	-
Other Financing Activities	-61.68	-74.18	-12.5	-	-	-
Financing Cash Flow	274.47	264.95	67.44	-5.13	194.6	-1.44
Foreign Exchange Rate Adjustments	0.07	-0.47	-	-	-	-
Net Cash Flow	-22.28	-76.23	167.89	-52.07	92.43	-54.49
Free Cash Flow	125.44	47.78	110.09	-40.08	0.77	9.13
Free Cash Flow Growth	26.02%	-56.60%	-	-	-91.62%	-76.58%
Free Cash Flow Margin	16.78%	7.78%	22.61%	-12.67%	0.35%	4.38%
Free Cash Flow Per Share	6.41	2.47	6.05	-2.46	0.06	0.76
Cash Interest Paid	22.09	24.38	31.43	21.48	9.71	6.93
Cash Income Tax Paid	18.33	19.06	1.23	0.29	10.37	4.98
Levered Free Cash Flow	89.39	28.57	114.36	-38.7	-28.62	-49.91
Unlevered Free Cash Flow	109.02	49.28	136.26	-20.94	-21.16	-43.99
Change in Working Capital	41.11	-11.19	24.86	-51.3	-0.08	-12.63

Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q